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Abstract
Background: Ankylosing spondylitis is a chronic inflammatory rheumatic disorder which usually
begins in early adulthood. The diagnosis is often delayed by many years. MR imaging has become
the preferred imaging method for detection of early inflammation of the axial skeleton in ankylosing
spondylitis.
The goal of this study was to assess the frequency and distribution of abnormalities on whole body
MR imaging in patients with suspected early ankylosing spondylitis and with active confirmed
ankylosing spondylitis.
Methods: Ten patients with suspected early ankylosing spondylitis and ten patients with confirmed
ankylosing spondylitis were enrolled. On an 18-channel MR system, coronal and sagittal T1
weighted and STIR sequences were acquired covering the entire spine, sacrum, anterior chest wall,
shoulder girdle, and pelvis. The total examination time was 30 minutes.
Results: In both groups inflammatory lesions of the lower thoracic spine were frequent (number
of patients with suspected early/confirmed ankylosing spondylitis: 7/9). In confirmed ankylosing
spondylitis the upper thoracic spine (3/6) and the lumbar spine (4/8) were more commonly
involved. The inferior iliac quadrant of the sacroiliac joints was frequently altered in both groups
(8/8). The superior iliac (2/5), inferior sacral (6/10) and superior sacral (3/6) quadrants were more
frequently affected in confirmed ankylosing spondylitis. Abnormalities of the manubriosternal joint
(2/4), the sternoclavicular joints (1/2) and hip joint effusion (4/3) were also seen.
Conclusion: In both suspected early ankylosing spondylitis and confirmed ankylosing spondylitis,
whole body MR examinations frequently demonstrate inflammatory lesions outside the sacroiliac
joints. These lesions are similarly distributed but occur less frequently in suspected early compared
to confirmed ankylosing spondylitis. Due to the small sample size in this pilot study these results
need to be confirmed in larger studies with this emerging technique.
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Background
Ankylosing spondylitis (AS) is a chronic inflammatory
rheumatic disorder mainly affecting the sacroiliac (SI)
joints and the spine. The leading symptom is inflamma-
tory back pain. The impairment of quality of life and the
socioeconomic consequences may be substantial [1-4].
Recently, symptomatically highly effective drugs such as
tumor necrosis factor alpha (TNFα) inhibitors have
gained increasing interest for treatment of AS [5]. Imaging
may play an important role in assessing disease activity at
an early stage and for the follow-up of the disorder under
these recently introduced treatment options. However,
the definition of an early stage of AS represents a method-
ological problem because there are no validated classifica-
tion or diagnostic criteria [6]. Inflammatory back pain
(IBP) is the leading early symptom of the closely interre-
lated forms of spondyloarthropathies, AS being the most
common entity of this disease group [7].
The diagnosis of AS is still delayed by more than seven
years in many patients [8,9]. MR imaging has become the
preferred imaging method for detection of early inflam-
mation of the spine and the SI joints in AS [10-16]. The
spinal segment most commonly affected by AS appears to
be the thoracic spine [13,17-19].
Advances in multichannel technology allow to perform
whole body MR imaging with visualization of inflamma-
tory lesions of the entire spine, the shoulder girdle, the
anterior chest wall and the pelvis, including the SI joints,
symphysis pubis and hip joints in a single examination.
Whole body MR imaging may provide characteristic pat-
terns of abnormalities in early and late AS in various
regions outside the SI joint which may contribute to early
diagnosis in patients with suspected AS. We hypothesized
that patients with suspected early AS may demonstrate a
similar pattern of abnormalities compared to patients
with longstanding and confirmed AS. Thus, the aim of this
study was to assess the frequency and patterns of abnor-
malities on whole body MR imaging in patients with sus-
pected early AS and active confirmed AS.
Methods
Study population
Ten patients with suspected early AS and ten patients with
active confirmed AS were prospectively recruited in our
outpatient department of rheumatology between Novem-
ber 2004 and August 2005 from a national population-
based prospective observational registry of AS patients
(Swiss Clinical Quality Management in Ankylosing
Spondylitis SCQM AS) which started in August 2004. Par-
ticipants in this registry were enrolled by practicing or
hospital based board certified rheumatologists.
The responsible institutional review boards (spezialisierte
Unterkommission Orthopaedie/Bewegungsapparat der
kantonalen Ethikkommission Zuerich; Ethik-Kommis-
sion [KEK], Gesundheitsdirektion Kanton Zuerich)
approved the protocol, and all patients gave written
informed consent.
Inclusion criteria
Patients were enrolled in the suspected early AS group if
they were suffering from inflammatory low back pain for
more than three months and for less than two years and if
at least one of the following features was present: Rapid
and substantial pain relief by non-steroidal antiinflam-
matory drugs, alternating buttock pain, peripheral arthri-
tis, enthesitis, dactylitis, uveitis, HLA B27 status positive,
elevated acute phase reactants, family history of AS.
Inflammatory back pain was defined as relapsing or per-
sisting low back pain, improving with exercise but not
relieved by rest, morning stiffness of at least 30 minutes
and awakening in the second half of the night due to low
back pain. At least two of the three latter criteria had to be
fulfilled by the patients in the group with suspected early
AS.
The term of suspected early AS was chosen because there
are no validated criteria for the diagnosis of early AS. The
commonly used modified New York classification criteria
[20] for AS use radiographic evidence of sacroiliitis as the
main item. Relapsing or persisting inflammatory back
pain is considered to be an early symptom of the closely
interrelated forms of spondyloarthropathies, AS being the
most common entity in this disease group.
Patients with confirmed AS were enrolled if they fulfilled
the modified New York criteria [20].
The minimal disease activity required for both groups to
be enrolled was a Bath Ankylosing Spondylitis Disease
Activity Index (BASDAI) of at least 4 and/or spine pain of
at least 4 (BASDAI item 2: second question of the BASDAI
instrument dealing with back pain) on a numeric rating
scale ranging from 0 to 10 [21]. A BASDAI value of 4 or
higher is considered to reflect a high disease activity.
Exclusion criteria
Exclusion criteria were clinical signs of psoriasis, SAPHO
syndrome (synovitis, acne, pustulosis, hyperostosis, ostei-
tis), chronic inflammatory bowel disease (Crohn's dis-
ease, ulcerative colitis) or reactive arthritis; previous or
ongoing treatment with tumor necrosis factor alpha
(TNFα)-inhibitors or other biologics; previous surgery of
the spine, pelvis or shoulder girdle; pregnancy within the
first 3 months, contraindications for MR imaging includ-
ing cardiac pacemakers and neurostimulators.BMC Musculoskeletal Disorders 2007, 8:20 http://www.biomedcentral.com/1471-2474/8/20
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MRI protocol
Whole body MR imaging was performed in all patients
using coronal and sagittal T1 weighted and short tau
inversion recovery (STIR) sequences of the entire spine
and sacrum, anterior chest wall and shoulder and pelvis.
MR imaging was performed on a 1.5 Tesla magnet (Sie-
mens Medical Solutions, Erlangen, Germany), equipped
with 18 independent radiofrequency channels. A body
matrix coil was used. Coronal T1 weighted spin echo (TR:
571 ms, TE: 12 ms, PAT Factor 2, PAT mode GRAPPA
[generalized autocalibrating partially parallel acquisi-
tion]) and coronal Turbo STIR (TR: 9860 ms, TE: 99 ms,
TI: 130 ms, Turbo Factor 21, PAT Factor 2, PAT mode
GRAPPA) sequences were acquired using two imaging
steps with a FOV of 450 mm × 450 mm and an imaging
Matrix of 348 × 267 pixels per step, 5 mm section thick-
ness, interslice gap 1 mm, 31 sections resulting in a FOV
of 785 × 450 mm. Sagittal T1 weighted spin echo (TR: 401
ms, TE: 11 ms, PAT Factor 2, PAT mode GRAPPA) and sag-
ittal turbo STIR (TR: 6270 ms, TE: 93 ms, TI: 130 ms,
Turbo Factor 21, PAT Factor 2, PAT mode GRAPPA) were
acquired using two imaging steps with a FOV of 450 mm
× 450 mm and an imaging matrix of 512 × 256 pixels per
step, 4 mm slice thickness, interslice gap 0.4 mm, 20 sec-
tions resulting in a FOV of 792 × 450 mm. The sum of the
acquisition times for all sequences including two localiz-
ers was 21 minutes 53 seconds. The total examination
time including patient positioning was 30 minutes.
Analysis of MR images
The MR images were analyzed by consensus between two
staff musculoskeletal radiologists (CP, MZ), who were
blinded with regard to the two patient groups. The films
were read in random order at a work station. Assessments
included inflammatory changes (edema-like signal abnor-
malities of bone marrow) of the spine and around the SI
joints as well as fatty replacement of subchondral bone
marrow of the SI joints. Assessment for the shoulders,
anterior chest wall and pelvis included edema-like signal
abnormalities of adjacent bone marrow and joint effu-
sion.
Spinal assessment was based on 23 vertebral units from
C2/C3 to L5/S1. A vertebral unit was defined as the region
between two virtual lines drawn through the middle of
each vertebra according to one of the recently published
MR scoring systems for inflammatory involvement of the
spine in AS [19]. Bone marrow signal abnormalities in
both adjacent vertebral bodies of the vertebral unit were
assessed irrespective of the extent of the lesions (possible
range: 0 to 23 lesions per patient). Inflammatory changes
of the spinous processes and the facet joints were noted.
The SI joints were divided into four quadrants each (supe-
rior and inferior iliac and sacral quadrants) regardless of
the extent of the lesions (possible range: 0 to 8 lesions per
patient).
In the anterior chest wall the sternoclavicular, costosternal
and manubriosternal joints were assessed. In the shoul-
ders the glenohumeral and acromioclavicular joints as
well as the subacromial bursa were included in the evalu-
ation. In the pelvis both hips and trochanteric regions and
the symphysis pubis were evaluated. Abnormal hip effu-
sion was defined as fluid adjacent to the entire length of
the femoral neck, measuring at least 5 mm in width [22].
Statistics
We compared means and medians. Since they did not fit
well to a normal distribution, we used a non-parametric
equality of medians test. It tests the null hypothesis that
the two samples (suspected early AS and confirmed AS)
were drawn from populations with the same median. A
computer software package (SPSS, version 11.5.0; SPSS,
Chicago, IL) was used to perform all statistical calcula-
tions.
Results
Patient characteristics (Table 1)
Ten patients had suspected early AS with a median disease
duration of 0.8 years (range 0.3 to 2.0 years; seven male
and three female patients; median age 28.5 years). Ten
patients had confirmed AS with a median disease dura-
tion of 12.5 years (range 6 to 28 years; seven male and
three female patients; median age 36.5 years).
The group with suspected early AS had a median BASDAI
of 4.6 (median spinal pain 6.0 according to BASDAI 2, the
second question of the BASDAI instrument dealing with
back pain; median erythrocyte sedimentation rate 8.0
mm/h). The confirmed AS group had a median BASDAI of
5.9, a median BASDAI 2 of 7.0 and a median erythrocyte
sedimentation rate of 16.5 mm/h.
The parameters of disease activity showed no statistically
significant differences between the two groups. A signifi-
cant difference in parameters of metrology (BASMI [Bath
Ankylosing Spondylitis Metrology Index; [24]]) most
probably reflects the longer disease duration of the con-
firmed AS group.
MR findings of the spine (Table 2; Figure 1, 2, 3)
Inflammatory lesions of the lower thoracic spine were fre-
quent in both groups: Fifteen lesions in 7 patients of the
group with suspected early AS and 21 lesions in 9 patients
of the confirmed AS group. Patients with confirmed AS
had more inflammatory lesions of the upper thoracic
spine (17 lesions in 6 patients versus 6 lesions in 3
patients in the suspected early AS group) and the lumbar
spine (18 lesions in 8 patients versus 5 lesions in 4BMC Musculoskeletal Disorders 2007, 8:20 http://www.biomedcentral.com/1471-2474/8/20
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patients in the suspected early AS group). Inflammatory
involvement of the cervical spine was rare with 5 lesions
in 3 patients of the confirmed AS group and 2 lesions in 2
patients of the suspected early AS group.
Inflammatory lesions of the spinous processes and the
facet joints of the spine were more common in the con-
firmed AS group. Involvement of the spinous processes
was found in 5 patients (9 lesions) in the confirmed AS
group (no findings in the suspected early AS group) and
involvement of the facet joints in 2 patients (4 lesions) in
the confirmed AS group versus 1 patient (2 lesions) in the
suspected early AS group.
MR findings of the SI joints (Table 2)
SI joints showed frequent inflammatory lesions in the
inferior iliac quadrant in both groups. There were 13
lesions in 8 patients in the suspected early AS group and
16 lesions in 8 patients in the confirmed AS group. The
remaining three sacroiliac quadrants were more fre-
quently affected in confirmed AS (confirmed AS group
versus suspected early AS group). There were 8 lesions in
5 patients versus 2 lesions in 2 patients in the superior
iliac quadrant; 15 lesions in 10 patients versus 8 lesions in
6 patients in the inferior sacral quadrant and 9 lesions in
6 patients versus 3 lesions in 3 patients in the superior sac-
ral quadrant.
Fatty replacement of subchondral bone marrow of the SI
joints (Figure 4) was more frequent in the confirmed AS
group (confirmed AS group versus suspected early AS
group). In the inferior iliac quadrant there were 10 lesions
in 6 patients versus 4 lesions in 3 patients. The corre-
sponding numbers were 2 lesions in 2 patients in both
groups for the superior iliac quadrant, 17 lesions in 9
patients versus 5 lesions in 4 patients in the inferior sacral
quadrant and 9 lesions in 6 patients versus 3 lesions in 3
patients in the superior sacral quadrant.
MR findings of the anterior chest wall (Table 2; Figure 5)
Inflammatory changes of the anterior chest wall were
found (suspected early AS group versus confirmed AS
group) in the manubriosternal joint in 6 patients (2 versus
4), in the sternoclavicular joints in 3 patients (1 versus 2)
and in the costosternal joints in 1 patient in the suspected
early AS group.
MR findings of the shoulder (Table 2)
Inflammatory changes of the shoulder were rare and con-
fined to the confirmed AS group. Abnormalities of the
acromioclavicular joint were seen in three patients and of
the subacromial bursa in one patient. None of the gleno-
humeral joints was affected.
MR findings of the pelvis (Table 2; Figure 6)
Seven patients had hip effusions (4 patients in the sus-
pected early AS group and 3 patients in the confirmed AS
group). In a single patient each with confirmed AS edema-
like abnormalities of the left femoral head and acetabu-
lum, the greater trochanter as well as the symphysis were
found.
MR findings suggestive of inflammatory lesions with regard 
to different localizations (Figure 7)
In both groups the highest percentage of patients with
inflammatory lesions was observed using the single
Table 1: Characteristics of the study patients
Suspected early ankylosing spondylitis group (n = 10) Confirmed ankylosing spondylitis group (n = 10)
Male : female 7 : 3 7 : 3
Age (years) 28.5 (21 – 45) 36.5 (30 – 48)
Disease duration (years) 0.8 (0.3 – 2.0) 12.5 (6 – 28)
HLA B27 positive (%) 90 90
BASDAI 4.6 (3.5 – 6.7) 5.9 (3.2 – 8.0)
BASDAI 2 6.0 (4 – 10) 7.0 (6 – 10)
BASFI 3.0 (0.5 – 6.2) 4.6 (0.8 – 7.8)
BASMI 1.0 (0 – 2) 2.0 (0 – 5)
ESR (mm/h) 8.0 (1 – 42) 16.5 (5 – 64)
Values presented are median (range) unless otherwise stated
BASDAI: Bath Ankylosing Spondylitis Disease Activity Index [21]; BASDAI 2: second question of the BASDAI instrument dealing with back pain; 
BASFI: Bath Ankylosing Spondylitis Functional Index [23]; BASMI: Bath Ankylosing Spondylitis Metrology Index [24]; ESR: Erythrocyte Sedimentation 
RateBMC Musculoskeletal Disorders 2007, 8:20 http://www.biomedcentral.com/1471-2474/8/20
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Table 2: Distribution of MR imaging lesions in the SI joints (four quadrants), in the spine (four regions), in the shoulder/pelvic girdle 
and the anterior chest wall
SI Joints: Inflammatory Lesions (four quadrants)
Suspected Early AS Patients Confirmed AS Patients
Patients Lesions Patients Lesions
Superior Ileal 2 2 5 8
Inferior Ileal 8 13 8 16
Superior Sacral 3 3 6 9
Inferior Sacral 6 8 10 15
SI Joints: Fatty Replacement of Bone Marrow (four quadrants)
Suspected Early AS Patients Confirmed AS Patients
Patients Lesions Patients Lesions
Superior Ileal 2 2 2 2
Inferior Ileal 3 4 6 10
Superior Sacral 3 3 6 9
Inferior Sacral 4 5 9 17
Spine: Inflammatory Lesions
Suspected Early AS Patients Confirmed AS Patients
Patients Lesions Patients Lesions
C-Spine (C2/3-C7/T1) 2 2 3 5
Upper T-Spine (T1/2-T6/7) 3 6 6 17
Lower T-Spine (T7/8-T12/L1) 7 15 9 21
L-Spine (L1/2-L5/S1) 4 5 8 18
Shoulder/pelvic girdle and anterior chest wall: Inflammatory Lesions
Suspected Early AS Patients Confirmed AS Patients
Sternoclavicular Joint 1 2
Manubriosternal Joint 2 4
Costosternal Junction 1 0
Acromioclavicular Joint 0 3
Glenohumeral Joint 0 0
Subacromial Bursa 0 1
Hip Joint 4 3
Greater Trochanter 0 1
Symphysis Pubis 0 1BMC Musculoskeletal Disorders 2007, 8:20 http://www.biomedcentral.com/1471-2474/8/20
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regions SI joints or thoracic spine. In this small sample
size a combination of the regions SI joints and any spinal
area detected all patients with inflammatory lesions.
Discussion
The diagnosis of AS may be delayed by more than seven
years [8,9]. The modified New York classification criteria
[20] are often used for diagnostic purposes. They depend
on the presence of sacroiliitis on standard radiographs
which develops late in the course of the disease [25,26].
There is a need for new criteria for early diagnosis of AS
[6].
The term of suspected early AS was chosen in this study
because there are no validated criteria for the diagnosis of
early AS. Relapsing or persisting inflammatory back pain
is considered to be an early symptom of the closely inter-
related forms of spondyloarthropathies, AS being the
most common entity in this disease group [7]. It will take
many years of follow-up of these 10 patients with sus-
pected early AS participating in a prospective observa-
tional registry to confirm the diagnosis of AS or another
form of spondyloarthritis. In a cohort of 88 patients with
possible AS (inflammatory low back pain and at least one
additional feature suggestive of spondyloarthritis), radio-
logical sacroiliitis became evident only after a mean dis-
ease duration of nine years [26].
In recent years MR imaging has proved to be a major
advance in detection of early inflammation of the spine
and the SI joints in AS [10-16]. If signal abnormalities of
bone marrow represent a specific inflammatory feature of
AS is controversial [27]. A correlation between clinical dis-
ease activity and acute inflammatory changes of the SI
Inflammatory lesions separated for each vertebral unit Figure 1
Inflammatory lesions separated for each vertebral unit. Numbers are patients with a positive finding. The white bars 
represent the patients with suspected early AS; the black bars represent the patients with confirmed AS.
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joints and the spine has been found in some studies
[19,28] contrasting with negative findings in others
[18,29]. Additional data are needed if the apparently
inflammatory lesions seen on MR imaging are indeed pre-
dictive of radiographic changes diagnosed some years
later [14]. The quality of information gained by the use of
STIR as the sole technique in imaging of inflammatory
lesions of the spine in confirmed AS was not inferior to
the use of gadolinium-enhanced T1-weighted imaging
with fat saturation [30].
Inflammatory MR lesions of the shoulders, the anterior
chest wall and the pelvis have not been extensively inves-
tigated in AS [13,31]. There is some evidence, however,
that inflammation of the hip joint may herald a poor
prognosis [32,33].
Whole body MR imaging with the so-called total imaging
matrix technology (TIM, Siemens Medical Solutions,
Erlangen, Germany) reduces imaging times by virtually
eliminating the need for patient repositioning and man-
ual coil changes. Whole body MR imaging allows the vis-
ualization of inflammatory changes in the entire spine
and the SI joints as well as of the shoulders, the anterior
chest wall and the pelvis within 30 minutes including ini-
tial positioning of the patient. Spatial resolution is similar
to standard MR examinations.
Inflammatory involvement of the lower thoracic spine
was common both in the confirmed AS and suspected
early AS group. This finding is in accordance with several
30-year old male patient with confirmed AS (duration of  inflammatory back pain 7 years, BASDAI 4.8, HLA B27 posi- tive) Figure 3
30-year old male patient with confirmed AS (duration of 
inflammatory back pain 7 years, BASDAI 4.8, HLA B27 posi-
tive). Sagittal STIR images show inflammatory lesions in the 
thoracic and lumbar spine (arrows). Inflammatory lesions of 
the spinous process are shown at L4 (curved arrow)
28-year old male patient with suspected early AS (duration of  inflammatory back pain 7 months, BASDAI 3.7, BASDAI 2 5,  HLA B27 positive) Figure 2
28-year old male patient with suspected early AS (duration of 
inflammatory back pain 7 months, BASDAI 3.7, BASDAI 2 5, 
HLA B27 positive). Coronal (left) and sagittal (right) STIR 
images show the most commonly seen signal abnormalities in 
suspected early AS. Inflammatory changes (open arrows) are 
seen in the lower aspects of the SI joints and subtle abnor-
malities in the anterior corner of the endplates in the tho-
racic spine (arrows).BMC Musculoskeletal Disorders 2007, 8:20 http://www.biomedcentral.com/1471-2474/8/20
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studies using conventional MR imaging [13,17-19].
Inflammatory changes in the thoracic spine seem to be
second in frequency only to inflammatory lesions in the
SI joints. This finding may contribute to early diagnosis of
AS and the lower thoracic spine should be included in MR
imaging protocols analyzing active AS [17]. Inflammatory
involvement of the lower lumbar spine without major
changes in the SI joints has been shown occasionally
[25,34].
In our study, inflammatory lesions of the SI joints were
most frequently found in the inferior iliac quadrant in
both groups. The remaining quadrants of the SI joints
were more frequently affected in confirmed AS. An assess-
ment of the SI joints by four quadrants seems to be justi-
fied by the consistent finding of early inflammation in the
inferior iliac quadrant (dorsocaudal synovial part of the
joint) [35,36]. A recently published study with MR-histo-
logical correlation of normal SI joints demonstrated that
the characteristics of a synovial joint were confined to the
distal cartilaginous portion at the iliac side [37].
Fatty replacement of subchondral bone marrow was com-
mon in our patients with confirmed AS. If this is a distinct
feature of confirmed AS is still open for discussion [38].
Fat conversion of a mostly patchy distribution has been
described in the sacral and iliac bone marrow in healthy
volunteers without known inflammatory disease
[15,39,40]. On the other hand, in a study of 41 patients
with early spondyloarthritis, fat accumulation in the bone
marrow was commonly associated with chronic inflam-
matory changes of the SI joints [12]. Based on the pres-
ence of joint fluid, the hip was relatively frequently
involved in our study (N = 7). Additional bone marrow
signal abnormalities of the left femoral head and acetabu-
lum were detected in one patient in the confirmed AS
group. This patient suffered from severe back pain with
extensive inflammatory lesions of all segments of the
34-year old male patient with confirmed AS (duration of  inflammatory back pain 13 years, BASDAI 4.9, HLA B27 pos- itive) Figure 5
34-year old male patient with confirmed AS (duration of 
inflammatory back pain 13 years, BASDAI 4.9, HLA B27 pos-
itive). Inflammatory lesions of the anterior chest wall are 
shown in the manubriosternal joint (curved arrows) on coro-
nal (left) and sagittal (right) STIR images. Inflammatory 
changes are seen in the lower thoracic spine and L1 
(arrows).
47-year old male patient with confirmed AS (duration of  inflammatory back pain 13 years, BASDAI 7.0, HLA B27 pos- itive) Figure 4
47-year old male patient with confirmed AS (duration of 
inflammatory back pain 13 years, BASDAI 7.0, HLA B27 pos-
itive). Fatty replacement of subchondral bone marrow is 
shown in the lower sacral quadrant (arrows) on the coronal 
T1-weighted image.BMC Musculoskeletal Disorders 2007, 8:20 http://www.biomedcentral.com/1471-2474/8/20
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spine but presented no signs of coxitis during the clinical
examination. In two retrospective studies on the long
term outcome covering a follow-up period of 38 and 10
years, respectively, hip joint involvement proved to be the
single most important risk factor predicting ankylosis of
the spine [32,33]. Whole body MR imaging is able to vis-
ualize inflammatory changes of the hip joints simultane-
ously with the SI joints and the spine.
Inflammatory changes in the manubriosternal joint were
found in six patients, in the sternoclavicular joints in three
patients and in the costosternal joints in one patient.
Inflammatory involvement of the anterior chest wall in
MR examinations has rarely been reported in AS [13].
Inflammatory lesions of the shoulders were confined to
the confirmed AS group. The most frequently affected
region was the acromioclavicular joint (N = 3). Inflamma-
tory involvement with intense bone marrow abnormality
at the supraspinatus insertion onto the greater tuberosity
and acromial entheses of the deltoid muscle has previ-
ously been described as a common and specific finding in
AS [31].
MR imaging is part of the Assessment in Ankylosing
Spondylitis (ASAS) International Working Group recom-
mendations for management of AS [41]. A collaborative
initiative of ASAS and OMERACT (Outcome Measures in
Rheumatoid Arthritis Clinical Trials) MR imaging in AS
working group has been started with the goal to validate
and standardize the available MR scoring systems for the
spine and the SI joints, using standard MR systems [27].
The additional information on inflammatory involve-
ment of the shoulders, of the anterior chest wall or of a
possibly prognostically important coxitis may be of clini-
cal importance. A systematic comparison of the quality of
information gained by whole body MR imaging with the
assessment of selected regions of the skeleton by conven-
tional MR imaging techniques has not been performed in
this study. However, the spatial resolution and other
imaging parameters obtained with the MR system
employed in this study are comparable to examinations
dedicated to a specific body region.
Conclusion
In conclusion, whole body MR examinations frequently
demonstrate inflammatory lesions outside the SI joints in
both confirmed AS and suspected early AS with a high dis-
ease activity judged on clinical grounds. These lesions are
similarly distributed but occur less frequently in suspected
early AS compared to confirmed AS. Due to the small sam-
ple size in this pilot study these results need to be con-
firmed in larger studies using this emerging technique.
Whole body MR imaging is a promising tool to assess the
frequency and distribution of inflammatory lesions in the
entire axial skeleton and the shoulder and pelvic girdle
both in patients with suspected early and with confirmed
active ankylosing spondylitis.
List of abbreviations
AS Ankylosing Spondylitis
ASAS Assessment in Ankylosing Spondylitis International
Working Group
BASDAI Bath Ankylosing Spondylitis Disease Activity
Index
BASFI Bath Ankylosing Spondylitis Functional Index
BASMI Bath Ankylosing Spondylitis Metrology Index
CRP C-Reactive Protein
ESR Erythrocyte Sedimentation Rate
HLA B27 Human Leukocyte Antigen B27
MR imaging Magnetic resonance imaging
NSAID Non-Steroidal Antiinflammatory Drug
30-year old male patient with confirmed AS (duration of  inflammatory back pain 7 years, BASDAI 4.8, HLA B27 posi- tive) Figure 6
30-year old male patient with confirmed AS (duration of 
inflammatory back pain 7 years, BASDAI 4.8, HLA B27 posi-
tive). Two coronal STIR images demonstrate inflammatory 
lesions in the thoracic spine (solid arrows), in the sacroiliac 
joint (sacral side) (open arrows), and in the left hip. Extensive 
bone marrow changes in the acetabulum (curved arrow) and 
an effusion of the hip joint are shown (arrowheads).BMC Musculoskeletal Disorders 2007, 8:20 http://www.biomedcentral.com/1471-2474/8/20
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MRI abnormalities suggestive of inflammatory lesions with regard to different localizations Figure 7
MRI abnormalities suggestive of inflammatory lesions with regard to different localizations. Numbers are patients 
with a positive finding. The white bars represent the patients with suspected early AS; the black bars represent the patients 
with confirmed AS. The wording "only" refers to inflammatory lesions when analyzing the selected region only irrespective of 
any additional inflammatory lesions seen in other localizations.
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